ArticleBone marrow transplantation2023
Increased CXCL10 is seen at 1-year after autologous hematopoietic cell transplantation in multiple myeloma patients on maintenance lenalidomide therapy.
Meera Mohan, Siegfried Janz, Ruta Brazauskas, Michael B Dwinell, Bi Qing Teng, Grant Yun, Jing Dong, Marcelo C Pasquini, Sergio Giralt, Heather Landau and 3 more
Open access · greenAbstract readLetter
In one paragraphArticle in Bone marrow transplantation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 79% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors at 4 institutions in 1 country.
Meera MohanDivision of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.ORCID 0000-0002-6913-6526 Siegfried JanzDivision of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.ORCID 0000-0002-2229-5511 Ruta BrazauskasDivision of Biostatistics, Institute of Health and Equity, Medical College of Wisconsin, Milwaukee, WI, USA.
Michael B DwinellCenter for Immunology, Department of Microbiology & Immunology, Medical College of Wisconsin, Milwaukee, WI, USA.
Bi Qing TengDivision of Biostatistics, Institute of Health and Equity, Medical College of Wisconsin, Milwaukee, WI, USA.
Grant YunMedical College of Wisconsin Medical School, Milwaukee, WI, USA.
Jing DongDivision of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.ORCID 0000-0001-9856-5963 Marcelo C PasquiniDivision of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Sergio GiraltDivision of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0003-1944-5053 Heather LandauDivision of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0002-3152-1189 Edward StadtmauerDepartment of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Amrita KrishnanDepartment of Hematology and Hematopoietic Cell Transplantation, City of Hope Cancer Center, Duarte, CA, USA.
Anita D'SouzaDivision of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. andsouza@mcw.edu.ORCID 0000-0002-1092-5643 Medical College of Wisconsin · USMemorial Sloan Kettering Cancer Center · USCity of Hope · USUniversity of Pennsylvania · US
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4MBlood and Marrow Transplant Clinical Trials Network DCC- The Medical College of Wisconsin, Inc.U24HL138660 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI Steven M. DeVine, Mehdi Hussain Hamadani · 2017 to 2026
$71.4MPB vs. BMU01HL069294 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI HOROWITZ, MARY MARESCA · 2001 to 2010
$63.3MEasy-to-read Informed Consent for HCT Clinical TrialsU10HL069294 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI HOROWITZ, MARY MARESCA · 2011 to 2016
$43.8MDefining genetic pathways of plasma-cell neoplasiaR01CA151354 · NCI · UNIVERSITY OF IOWA · PI JANZ, SIEGFRIED · 2010 to 2022
$3.9MTowards a better understanding of the critical role and therapeutic potential of drug resistant genes in multiple myelomaR01CA236814 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI FENGHUANG ZHAN · 2020 to 2026
$2.5MCity of Hope Core Clinical Center for the Blood and Marrow Transplant Clinical Trials NetworkUG1HL069278 · NHLBI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI RYOTARO NAKAMURA · 2017 to 2026
$2.2MBiased chemokine receptor signaling in cancer progressionR01CA226279 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI DWINELL, MICHAEL B · 2019 to 2023
$1.9MPrognostic implications of mitochondrial inheritance in myelodysplastic syndromes after stem-cell transplantationK01HL164972 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI Jing Dong · 2023 to 2026
$697kDevelopment and validation of a disease-relevant patient-reported outcome tool in light chain amyloidosisK23HL141445 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI D'SOUZA, ANITA · 2019 to 2022
$597kNCI NIH HHS P30 CA008748NCI NIH HHS R01 CA151354NCI NIH HHS R01 CA226279NCI NIH HHS R01 CA236814NHLBI NIH HHS K01 HL164972NHLBI NIH HHS K23 HL141445NHLBI NIH HHS U01 HL069294NHLBI NIH HHS U10 HL069294NHLBI NIH HHS U24 HL138660NHLBI NIH HHS UG1 HL069278
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Hematopoietic Stem Cell TransplantationMultiple MyelomaBortezomibChemokine CXCL10HumansLenalidomideMaintenance ChemotherapyThalidomideTransplantation, AutologousBortezomibChemokine CXCL10CXCL10 protein, humanLenalidomideThalidomide
Identifiers
PMID37149674
PMCPMC10555486
OpenAlexW4372346354
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390